Literature DB >> 19457807

Imaging localized prostate cancer: current approaches and new developments.

Baris Turkbey1, Paul S Albert, Karen Kurdziel, Peter L Choyke.   

Abstract

OBJECTIVE: Prostate cancer is the most common noncutaneous malignancy among men in the Western world. Imaging has recently become more important in the diagnosis, local staging, and treatment follow-up of prostate cancer. In this article, we review conventional and functional imaging methods as well as targeted imaging approaches with novel tracers used in the diagnosis and staging of prostate cancer.
CONCLUSION: Although prostate cancer is the second leading cause of cancer death in men, imaging of localized prostate cancer remains limited. Recent developments in imaging technologies, particularly MRI and PET, may lead to significant improvements in lesion detection and staging.

Entities:  

Mesh:

Year:  2009        PMID: 19457807      PMCID: PMC3523175          DOI: 10.2214/AJR.09.2527

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  90 in total

1.  Correlation of transrectal ultrasound, computer analysis of transrectal ultrasound and histopathology of radical prostatectomy specimen.

Authors:  H P Beerlage; R G Aarnink; E Th Ruijter; J A Witjes; H Wijkstra; C A Van De Kaa; F M J Debruyne; J J M C H De La Rosette
Journal:  Prostate Cancer Prostatic Dis       Date:  2001       Impact factor: 5.554

2.  Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.

Authors:  David M Schuster; John R Votaw; Peter T Nieh; Weiping Yu; Jonathon A Nye; Viraj Master; F DuBois Bowman; Muta M Issa; Mark M Goodman
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

3.  11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging.

Authors:  Soichiro Yoshida; Kazuaki Nakagomi; Shuichi Goto; Masami Futatsubashi; Tatsuo Torizuka
Journal:  Urol Int       Date:  2005       Impact factor: 2.089

4.  Radiolabeled monoclonal antibody indium 111-labeled CYT-356 localizes extraprostatic recurrent carcinoma after prostatectomy.

Authors:  P E Levesque; P T Nieh; L N Zinman; D W Seldin; J A Libertino
Journal:  Urology       Date:  1998-06       Impact factor: 2.649

5.  Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations.

Authors:  L E Moses; D Shapiro; B Littenberg
Journal:  Stat Med       Date:  1993-07-30       Impact factor: 2.373

6.  Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging.

Authors:  K K Yu; J Scheidler; H Hricak; D B Vigneron; C J Zaloudek; R G Males; S J Nelson; P R Carroll; J Kurhanewicz
Journal:  Radiology       Date:  1999-11       Impact factor: 11.105

7.  Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer.

Authors:  M J Manyak; G H Hinkle; J O Olsen; R P Chiaccherini; A W Partin; S Piantadosi; J K Burgers; J H Texter; C E Neal; J A Libertino; G L Wright; R T Maguire
Journal:  Urology       Date:  1999-12       Impact factor: 2.649

8.  Detection of bony metastases of androgen-independent prostate cancer by PET-FDG.

Authors:  S D Yeh; M Imbriaco; S M Larson; D Garza; J J Zhang; H Kalaigian; R D Finn; D Reddy; S M Horowitz; S J Goldsmith; H I Scher
Journal:  Nucl Med Biol       Date:  1996-08       Impact factor: 2.408

9.  Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy.

Authors:  Tim Joseph; David A McKenna; Antonio C Westphalen; Fergus V Coakley; Shoujun Zhao; Ying Lu; I-Chow Hsu; Mack Roach; John Kurhanewicz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-28       Impact factor: 7.038

10.  Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy.

Authors:  Herb Singh; Eduardo I Canto; Shahrokh F Shariat; Dov Kadmon; Brian J Miles; Thomas M Wheeler; Kevin M Slawin
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

View more
  61 in total

Review 1.  Image guidance in the focal treatment of prostate cancer.

Authors:  Anthony N Hoang; Dmitry Volkin; Nitin K Yerram; Srinivas Vourganti; Jeffrey Nix; W Marston Linehan; Bradford Wood; Peter A Pinto
Journal:  Curr Opin Urol       Date:  2012-07       Impact factor: 2.309

2.  Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapy.

Authors:  Luca F Valle; Matthew D Greer; Joanna H Shih; Tristan Barrett; Yan Mee Law; Andrew B Rosenkrantz; Haytham Shebel; Akhil Muthigi; Daniel Su; Maria J Merino; Bradford J Wood; Peter A Pinto; Andra V Krauze; Aradhana Kaushal; Peter L Choyke; Barış Türkbey; Deborah E Citrin
Journal:  Diagn Interv Radiol       Date:  2018 Jan-Feb       Impact factor: 2.630

3.  Utility of ADC measurement on diffusion-weighted MRI in differentiation of prostate cancer, normal prostate and prostatitis.

Authors:  Meltem Esen; Mehmet Ruhi Onur; Nusret Akpolat; Irfan Orhan; Ercan Kocakoc
Journal:  Quant Imaging Med Surg       Date:  2013-08

4.  Comparing nonrigid registration techniques for motion corrected MR prostate diffusion imaging.

Authors:  C Buerger; J Sénégas; S Kabus; H Carolus; H Schulz; H Agarwal; B Turkbey; P L Choyke; S Renisch
Journal:  Med Phys       Date:  2015-01       Impact factor: 4.071

5.  Is endorectal coil necessary for the staging of clinically localized prostate cancer? Comparison of non-endorectal versus endorectal MR imaging.

Authors:  Seung Hwan Lee; Kyung Kgi Park; Kyung Hwa Choi; Beom Jin Lim; Joo Hee Kim; Seung Wook Lee; Byung Ha Chung
Journal:  World J Urol       Date:  2010-07-11       Impact factor: 4.226

6.  Office ultrasound for the urologist.

Authors:  Etai Goldenberg; Bruce R Gilbert
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

7.  Magnetic resonance imaging for prostate cancer clinical application.

Authors:  Bing Li; Yong Du; Hanfeng Yang; Yayong Huang; Jun Meng; Dongmei Xiao
Journal:  Chin J Cancer Res       Date:  2013-04       Impact factor: 5.087

8.  Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds.

Authors:  Baris Turkbey; Haresh Mani; Vijay Shah; Ardeshir R Rastinehad; Marcelino Bernardo; Thomas Pohida; Yuxi Pang; Dagane Daar; Compton Benjamin; Yolanda L McKinney; Hari Trivedi; Celene Chua; Gennady Bratslavsky; Joanna H Shih; W Marston Linehan; Maria J Merino; Peter L Choyke; Peter A Pinto
Journal:  J Urol       Date:  2011-09-25       Impact factor: 7.450

Review 9.  Current Status of Hybrid PET/MRI in Oncologic Imaging.

Authors:  Andrew B Rosenkrantz; Kent Friedman; Hersh Chandarana; Amy Melsaether; Linda Moy; Yu-Shin Ding; Komal Jhaveri; Luis Beltran; Rajan Jain
Journal:  AJR Am J Roentgenol       Date:  2015-10-22       Impact factor: 3.959

10.  [Imaging diagnostics of advanced prostate cancer].

Authors:  A Kretschmer; M Seitz; A Graser; C G Stief; D Tilki
Journal:  Urologe A       Date:  2013-04       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.